Literature DB >> 24225952

Actin-binding and cell proliferation activities of angiomotin family members are regulated by Hippo pathway-mediated phosphorylation.

Siew Wee Chan1, Chun Jye Lim, Fusheng Guo, Ivan Tan, Thomas Leung, Wanjin Hong.   

Abstract

Whether the Hippo pathway has downstream targets other than YAP and TAZ is unknown. In this report, we have identified angiomotin (Amot) family members as novel substrates of Hippo core kinases. The N-terminal regions of Amot proteins contain a conserved HXRXXS consensus site for LATS1/2-mediated phosphorylation. Phospho-specific antibodies showed that Hippo core kinases could mediate phosphorylation of endogenous as well as exogenous Amot family members. Knockdown of LATS1 and LATS2 endogenously reduced the phosphorylation of Amots detected by the phospho-specific antibodies. Mutation of the serine to alanine within this HXRXXS site in Amot and AmotL2 established that this site was essential for Hippo core kinase-mediated phosphorylation. Wild-type and non-phosphorylated Amot (Amot-S175A) were targeted to actin filaments, whereas phospho-mimic Amot (Amot-S175D) failed to be localized with actin. Overexpression of LATS2 caused dissociation of Amot from actin but not Amot-S175A. Mapping of the actin-binding site of Amot showed that serine 175 of Amot was important for the actin-binding activity. Amot-S175A promoted, whereas Amot and Amot-S175D inhibited, cell proliferation. These results collectively suggest that the Hippo pathway negatively regulates the actin-binding activity of Amot family members through direct phosphorylation.

Entities:  

Keywords:  Actin; Angiomotin; Cell Proliferation; Hippo Pathway; LATS Kinase; Phosphorylation; Protein Kinases; Signal Transduction

Mesh:

Substances:

Year:  2013        PMID: 24225952      PMCID: PMC3873582          DOI: 10.1074/jbc.M113.527598

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Angiomotin-like proteins associate with and negatively regulate YAP1.

Authors:  Wenqi Wang; Jun Huang; Junjie Chen
Journal:  J Biol Chem       Date:  2010-12-27       Impact factor: 5.157

2.  A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells.

Authors:  Siew Wee Chan; Chun Jye Lim; Ke Guo; Chee Peng Ng; Ian Lee; Walter Hunziker; Qi Zeng; Wanjin Hong
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

Review 3.  The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.

Authors:  Bin Zhao; Karen Tumaneng; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2011-08-01       Impact factor: 28.824

4.  A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions.

Authors:  Chunling Yi; Scott Troutman; Daniela Fera; Anat Stemmer-Rachamimov; Jacqueline L Avila; Neepa Christian; Nathalie Luna Persson; Akihiko Shimono; David W Speicher; Ronen Marmorstein; Lars Holmgren; Joseph L Kissil
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

5.  Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.

Authors:  Bin Zhao; Li Li; Qing Lu; Lloyd H Wang; Chen-Ying Liu; Qunying Lei; Kun-Liang Guan
Journal:  Genes Dev       Date:  2011-01-01       Impact factor: 11.361

Review 6.  The Hippo pathway in biological control and cancer development.

Authors:  Siew Wee Chan; Chun Jye Lim; Liming Chen; Yaan Fun Chong; Caixia Huang; Haiwei Song; Wanjin Hong
Journal:  J Cell Physiol       Date:  2011-04       Impact factor: 6.384

7.  Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells.

Authors:  Mira Ernkvist; Olivier Birot; Indranil Sinha; Niina Veitonmaki; Staffan Nyström; Karin Aase; Lars Holmgren
Journal:  Biochim Biophys Acta       Date:  2007-12-08

8.  WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ.

Authors:  S W Chan; C J Lim; C Huang; Y F Chong; H J Gunaratne; K A Hogue; W P Blackstock; K F Harvey; W Hong
Journal:  Oncogene       Date:  2010-10-25       Impact factor: 9.867

9.  Hippo pathway-independent restriction of TAZ and YAP by angiomotin.

Authors:  Siew Wee Chan; Chun Jye Lim; Yaan Fun Chong; Ajaybabu V Pobbati; Caixia Huang; Wanjin Hong
Journal:  J Biol Chem       Date:  2011-01-11       Impact factor: 5.157

10.  Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor.

Authors:  Murugan Paramasivam; Ali Sarkeshik; John R Yates; Maria J G Fernandes; Dannel McCollum
Journal:  Mol Biol Cell       Date:  2011-08-10       Impact factor: 4.138

View more
  44 in total

1.  YAP activates the Hippo pathway in a negative feedback loop.

Authors:  Xiaoming Dai; Huan Liu; Shuying Shen; Xiaocan Guo; Huan Yan; Xinyan Ji; Li Li; Jun Huang; Xin-Hua Feng; Bin Zhao
Journal:  Cell Res       Date:  2015-08-28       Impact factor: 25.617

2.  RHOA activity in expanding blastocysts is essential to regulate HIPPO-YAP signaling and to maintain the trophectoderm-specific gene expression program in a ROCK/actin filament-independent manner.

Authors:  Yusuke Marikawa; Vernadeth B Alarcon
Journal:  Mol Hum Reprod       Date:  2019-02-01       Impact factor: 4.025

Review 3.  Cell Junctions in Hippo Signaling.

Authors:  Ruchan Karaman; Georg Halder
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

4.  Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.

Authors:  Sebastian Mana-Capelli; Dannel McCollum
Journal:  J Biol Chem       Date:  2018-09-28       Impact factor: 5.157

Review 5.  Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway.

Authors:  Ursula Ehmer; Julien Sage
Journal:  Mol Cancer Res       Date:  2015-10-02       Impact factor: 5.852

Review 6.  Control of cellular responses to mechanical cues through YAP/TAZ regulation.

Authors:  Ishani Dasgupta; Dannel McCollum
Journal:  J Biol Chem       Date:  2019-10-08       Impact factor: 5.157

7.  Angiomotin regulates budding and spread of Ebola virus.

Authors:  Ziying Han; Gordon Ruthel; Shantoshini Dash; Corbett T Berry; Bruce D Freedman; Ronald N Harty; Olena Shtanko
Journal:  J Biol Chem       Date:  2020-05-07       Impact factor: 5.157

8.  Angiomotin-like 2 interacts with and negatively regulates AKT.

Authors:  H Han; B Yang; W Wang
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

Review 9.  The Angiomotins--from discovery to function.

Authors:  Susana Moleirinho; William Guerrant; Joseph L Kissil
Journal:  FEBS Lett       Date:  2014-02-15       Impact factor: 4.124

10.  Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.

Authors:  Miju Kim; Minchul Kim; Seong-Jun Park; Cheolju Lee; Dae-Sik Lim
Journal:  EMBO Rep       Date:  2015-11-23       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.